Citeline Podcasts-logo

Citeline Podcasts

Business & Economics Podcasts

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

Location:

United States

Description:

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

Language:

English


Episodes
Ask host to enable sharing for playback control

Lung Life AI's CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic, Lung LB

6/21/2024
In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI’s journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement and compliance with the US FDA Lab Developed Test ruling.

Duration:00:26:24

Ask host to enable sharing for playback control

The Power Of Herbs For Women’s Wellness, With The SABI’s Hilary Metcalfe and Anna Cave-Bigley

6/17/2024
In this episode, HBW Insight chats with women’s health start-up The SABI about the power of herbal medicine for hormonal wellness. “Inspired by a series of painfully honest conversations they had about their hormonal and emotional challenges,” The SABI markets a range of herbal infusions aimed at alleviating some of the impacts of painful periods and hormonal imbalances, such as digestive discomfort, sleep disruption and anxiety. The SABI founders Hilary Metcalfe and Anna Cave-Bigley also reveal the difficulties of being a woman-led, women’s health startup in a male dominated world, especially when it comes to funding and research. We also discuss the importance of getting the message right, both in terms of connecting women to their hormonal health but also distinguishing The SABI from less credible women’s wellness brands. Timestamps: 2:00 Introductions 5:00 The power of herbs 11:45 The challenges of being a women’s health startup 17:30 The demand for natural women’s health products 24:50 Controversies surrounding natural women’s health alternatives 32:45 What’s next for The SABI Biographies Anna Cave-Bigley is CEO at The SABI, leading sales and strategy “with her signature drive and keen insight on everything from motherhood, hormone balance and mental health to strategy, sales and global operations.” From being a founding member of the international practice for a leading London communication consultancy to spearheading international investment initiatives for the British Government, Anna has honed her operational business expertise over 13 years. She is mother to Lorenzo and Alfie, who “inspired her to co-found The SABI after her devastating experience with clinical postpartum depression.” Co-founder Hilary Metcalfe is a Harvard graduate and accomplished business strategist, who dedicated 12 years to impact investment, sustainability, and management consulting before her health intervened. “Conventional medicine offered only a lifetime of medication for chronic migraines and my then-undiagnosed endometriosis. Determined to find a more natural approach, I became a certified holistic nutritionist, product developer and chef, building and selling a successful plant-based food startup in Amsterdam.” During this time Hilary began formulating the remedies and products that would become The SABI’s core collection.

Duration:00:35:21

Ask host to enable sharing for playback control

Scrip's Five Must-Know Things - 17 June 2024

6/16/2024
Audio roundup of selected biopharma industry content from Scrip over the business week ended 14 June 2024. In this episode: Boehringer best in MASH?; biopharma funding on an upswing?; Moderna’s combo jab; clinical trial recover from pandemic; and Astellas’s US commercial head speaks. https://scrip.citeline.com/SC150442/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: https://soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Duration:00:15:45

Ask host to enable sharing for playback control

Building And Scaling Your Workforce: The Importance Of A Flexible Delivery Model In 2024 & Beyond

6/14/2024
In this podcast, Janelle Hart, Managing Editor, Citeline, joins industry experts Jessica Wall, Director of Talent Acquisition, and Morgan Seaman, Associate Director of FSS Operations, both from Advanced Clinical, to discuss the latest trends and challenges in building, scaling and differentiating workforces in the life sciences sector. Talent acquisition is central to fostering creativity and innovation within any organization. In today’s highly competitive and fast-moving life sciences sector, it’s more important than ever. Tune into this free podcast to gain valuable insights on maintaining a competitive edge through innovative recruitment and retention strategies. Listen now to explore more!

Duration:00:22:44

Ask host to enable sharing for playback control

June 2024 Datamonitor Healthcare Podcast: ASCO 2024

6/14/2024
The oncology team from Datamonitor Healthcare and healthcare journalist, Alaric, provide broad analytical coverage of key highlights from the ASCO 2024 conference. Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836​ Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZXJzOjEwNjU1NDkyOC9zb3VuZHMucnNz​ TuneIn - https://tunein.com/podcasts/Business--Economics-Podcasts/Pharma-Intelligence-Podcasts-p1140128/​ Spotify Podcasts - https://open.spotify.com/show/3DTc3eIh4xI6pVOd6DdO67​

Duration:00:43:35

Ask host to enable sharing for playback control

China Biotech Podcast - 14 June 2024 (Bilingual Chinese/English)

6/14/2024
Guest speaker, US-based Pink Sheet senior writer Sarah Karlin-Smith, joins Brian Yang and Dexter Yan in China to discuss the recent BIO Conference, updates to the planned US BIOSECURE Act and industry preparations for its impact. Dexter also discusses China biotech's data highlights from ASCO 2024. https://scrip.citeline.com/SC150438/China-Biotech-Podcast-BIOSECURE-Act-Updates--ASCO-Highlights Playlist: https://soundcloud.com/citelinesounds/sets/chinese-language-biopharma

Duration:00:27:10

Ask host to enable sharing for playback control

ASCO 결산: 암 연구의 미래는? (Korean-language podcast)

6/12/2024
글로벌 제약업계는 암 연구의 미래를 어떻게 보고 있을까? Scrip의 ASCO 현장 취재 기사를 요약한 내용입니다. https://scrip.citeline.com/SC150378/ASCO-Roundup-Looking-For-The-Future-Of-Cancer-Research Playlist: https://soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini

Duration:00:03:38

Ask host to enable sharing for playback control

Scrip's Five Must-Know Things - 10 June 2024

6/9/2024
Audio roundup of selected biopharma industry content from Scrip over the business week ended 7 June 2024. In this episode: BIO Notebook; ASCO roundup; data on Carvykti in community at ASCO; strong new results for tirzepatide in MASH; and orphan slowdown signals new path ahead. https://scrip.citeline.com/SC150401/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Duration:00:15:38

Ask host to enable sharing for playback control

The Generics Bulletin Podcast: Teva, Sandoz, Sawai and US Orange Book patents

6/7/2024
Generics Bulletin's editorial team discusses the latest strategic developments for major industry players Teva, Sandoz and Sawai, as well as explaining the recent debate over US patent listings in the FDA's Orange Book.

Duration:00:24:18

Ask host to enable sharing for playback control

China Biotech Podcast - 5 June 2024 (Chinese language)

6/4/2024
Guest speaker Guangzuo Luo, chief scientific officer of Bioncetech, joins China-based editors Brian Yang and Dexter Yan in this episode, which looks at Chinese biotechs going global, and the opportunities and challenges in the latest industry latest trends. https://scrip.citeline.com/SC150370/China-Biotech-Podcast-Going-Global-Trends-Rare-Disease-Drug-Development Playlist: https://soundcloud.com/citelinesounds/sets/chinese-language-biopharma?si=80b1209c44874afa9c44bf7d30538320&utm_source=clipboard&utm_medium=text&utm_campaign=social_sharing

Duration:00:23:09

Ask host to enable sharing for playback control

JB CEO On CDMO Growth, Red Sea Crisis And More

6/3/2024
In an interview with Scrip, JB CEO Nikhil Chopra addresses rumours of a sale of a stake in the Indian pharma/CDMO company by private equity fund KKR, recent acquisitions, including from Novartis, as well as JB's ambitions to ramp up the cardiology segment and its CDMO business, which already has major clients including J&J. https://scrip.citeline.com/SC150350/Amid-Talk-Of-KKR-Stake-Sale-JB-CEO-Stresses-Business-As-Usual

Duration:00:34:06

Ask host to enable sharing for playback control

Scrip's Five Must-Know Things - 3 June 2024

6/3/2024
Audio roundup of selected biopharma industry content from Scrip over the business week ended 31 May 2024. In this episode: ASCO preview; Asahi’s US acquisition; Novartis aims for renal disease dominance; paying for gene therapies; and US BIOSECURE Act diluted. https://scrip.citeline.com/SC150361/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: https://soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Duration:00:15:09

Ask host to enable sharing for playback control

The Scrip Awards Podcast. Episode 1: Genmab: The Ongoing Evolution Of Europe’s Antibody Powerhouse

5/31/2024
An interview with Genmab’s Jan van de Winkel to mark 25 years of the company, and 20 years of the Scrip Awards. A brief history of the antibody-focused biotech company so far, and its plans for future expansion.

Duration:00:22:15

Ask host to enable sharing for playback control

How Corporate Sustainability Reporting ‘Just Got Serious,’ With CEN-ESG’s Jasper Crone

5/31/2024
In this episode we unpack the Corporate Sustainability Reporting Directive (CSRD) with the help of ESG expert Jasper Crone, drilling down into exactly what consumer healthcare companies need to know about this enormously complex and significant piece of EU legislation. 3:30 Introduction to the CSRD 7:45 What companies are affected by the CSRD 15:00 Specific implications for consumer health companies 21:00 Getting materiality right 25:00 CSRD to do list 32:00 Who’s afraid of targets? 37:00 Who’s responsible for CSRD in companies? 39:00 CSRD and the EU Green Deal 45:00 How will CSRD shape the way companies operate?

Duration:00:50:18

Ask host to enable sharing for playback control

Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions

5/31/2024
Advancing Investigational New Drugs (INDs) can be a complex process, especially for smaller companies. Listen to your free podcast now as Marcus Delatte, PhD, Vice President at Allucent and Harshini Neelakantan, Executive Director at Ridgeline Therapeutics discuss best practices and considerations for leveraging your pre-IND meeting and submitting a successful IND application. Listen now for insights into: • Current trends and challenges related to IND submissions • The purpose and benefits of pre-IND meetings with regulatory bodies • Indicators that should prompt companies to request a pre-IND meeting • The role of consultants in supporting sponsors in pre-IND meetings • Getting the most from your pre-IND meeting and tips for IND application success • How IND submissions will evolve in the future

Duration:00:37:01

Ask host to enable sharing for playback control

'CorpPharma Is Not Just A Cost Component’ – Showcasing Value As Well As Innovation

5/29/2024
Astellas Pharma’s chief commercial officer, Claus Zieler, discusses the biopharma industry’s responsibility to drive change in health care.

Duration:00:35:52

Ask host to enable sharing for playback control

China Biotech CEO Interview - NeuShen's Joan Huaqiong Shen

5/28/2024
NeuShen CEO Joan Shen discusses with Brian Yang about developing CNS drugs in China, the venture's business rationale, challenges and fundraising. She also discusses two leading assets for schizophrenia and epilepsy in first-in-human studies, as well as a gene therapy collaboration for ALS with UMass's Gao Lab. https://scrip.citeline.com/SC150328/China-Biotech-CEO-Interview-Starting-A-CNS-Venture-In-An-Economic-Downturn Playlist: https://on.soundcloud.com/AaFyPUxfD2RiDEis5

Duration:00:45:35

Ask host to enable sharing for playback control

Citeline Japan Awards 2024 - Enter Now! (Bilingual English/Japanese)

5/27/2024
As the 15 July entry deadline for the 3rd edition of the annual Citeline Japan Awards approaches, join us in this bilingual English/Japanese podcast to learn more about the categories and event itself. (Japanese starts at 2' 25".) English event site: https://www.citeline.com/en/awards/citelinejapanawards Japanese event site: https://www.citeline.com/ja-jp/awards/citelinejapanawards

Duration:00:05:16

Ask host to enable sharing for playback control

Scrip's Five Must-Know Things - 27 May 2024

5/27/2024
Audio roundup of selected biopharma industry content from Scrip over the business week ended 24 May 2024. In this episode: Biogen’s immunology acquisition; AstraZeneca looks to cement respiratory lead; why US FTC is tough on pharma; the US election’s impact on pharma; and how new AI tools are impacting medical affairs. https://scrip.citeline.com/SC150324/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: https://soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Duration:00:16:00

Ask host to enable sharing for playback control

Drug Fix: Novel Clinical Trial Reg Problems, NIH Drug ‘Access Plans’, Good Ole Days Of Woodcock

5/24/2024
Pink Sheet editors discuss the US FDA’s consideration of regulatory changes to promote innovative clinical trial designs (:32), an NIH proposal to require patent licensees create plans to ensure access to the commercialized product (7:29), and lawmakers longing for the days when Janet Woodcock ran the FDA’s Center for Drug Evaluation and Research (15:35). More On These Topics From The Pink Sheet ‘Antiquated’ Regulations Slowing Adoption of Innovative Clinical Trial Approaches: https://pink.citeline.com/PS154730/Antiquated-Regulations-Slowing-Adoption-of-Innovative-Clinical-Trial-Approaches US FDA Looking To Modernize Clinical Trial Regulations To Spur ‘Evolution’ In Research: https://pink.citeline.com/PS154721/US-FDA-Looking-To-Modernize-Clinical-Trial-Regulations-To-Spur-Evolution-In-Research NIH Drug Patent Licensees Would Develop ‘Access Plan’ Under Proposal; Pricing Commitments Optional: https://pink.citeline.com/PS154744/NIH-Drug-Patent-Licensees-Would-Develop-Access-Plan-Under-Proposal-Pricing-Commitments-Optional Woodcock Nostalgia: GOP Rep. Bilirakis Wants CDER To Recapture Her Flexible Approach: https://pink.citeline.com/PS154745/Woodcock-Nostalgia-GOP-Rep-Bilirakis-Wants-CDER-To-Recapture-Her-Flexible-Approach

Duration:00:23:09